Joint Formulary & PAD

Phytomenadione - Anticoagulation reversal

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous injection (IV)
Associated Icons :
Restrictions / Comments :
Important
https://www.toxbase.org/

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Phytomenadione
Indication :
Anticoagulation reversal
Group Name :
Keywords :
reversal of vitamin K anticoagulants, warfarin reversal
Brand Names Include :
Important Information :
https://www.toxbase.org/
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Phytomenadione is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Anticoagulation reversal.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.